From a health system perspective, Martyn suggested that broader formulary access to finerenone makes sense as long as patient ...
AJMC: Your study found that emphysema affecting at least 20% of the lung on CT was consistently associated with differences ...
The randomized controlled period (RCP) in the phase 3 MINT trial of inebilizumab for myasthenia gravis (MG) wasn't reported ...
Switching Medicare Advantage (MA) plans is increasingly common among MA enrollees, especially those dually eligible for ...
The One Big Beautiful Bill Act restructures Medicaid coverage in ways that have a direct impact on oncology programs. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results